Trial Profile
Phase I dose-escalation study evaluating the safety and efficacy of Multikine in HIV-infected patients with HPV-induced cervical dysplasia
Status:
Discontinued
Phase of Trial:
Phase I
Latest Information Update: 23 Oct 2013
Price :
$35
*
At a glance
- Drugs Buffy coat interleukins (Primary)
- Indications Cervical cancer; Cervical dysplasia
- Focus Adverse reactions; Therapeutic Use
- 23 Oct 2013 New trial record
- 07 Oct 2013 This study had been approved by the Human Subjects Institutional Review Board, according to a CEL-SCI Corporation media release.